Attend CSSi LifeSciences J.P. Morgan Healthcare Partnering Forum

Advancing Drugs and Medical Device Technologies
from Discovery to Commercialization

Regulatory

We offer regulatory affairs services to accelerate product approval by handling the communications and submission for our clients.

Regulatory

We offer regulatory affairs services to accelerate product approval by handling the communications and submission for our clients.

Strategy

Based on the indications and medical claims, we develop an accelerated approval roadmap with our team of experts using an integrated and adaptive approach to commercialization.

Strategy

Based on the indications and medical claims, we develop an accelerated approval roadmap with our team of experts using an integrated and adaptive approach to commercialization.

Clinical

From protocol development to biostatistics and data management, our team is positioned to support all aspects of your clinical trial.

Clinical

From protocol development to biostatistics and data management, our team is positioned to support all aspects of your clinical trial.

Commercialization

Raising funds? We have helped our clients raise over $700M USD of capital over the past decade. Join our innovative community today!

Commercialization

Raising funds? We have helped our clients raise over $700M USD of capital over the past decade. Join our innovative community today!

Management and Strategy
Cross-Functional Services

Project Management

Let us provide an extra pair of hands to move your assets forward. Our team can manage development activities including vendor sourcing, R&D and manufacturing.

Expert Team

Assembling a team of experts can be prohibitively expensive. Let us supplement your team and bring our expertise to keep you on track.

What we do in more detail

Key Performance Stats

%

We maintain a 100% success rate in medical device approvals by the US FDA.

Through our partnering and investor relation programs, we have helped raise over $700M in dilutive capital for our clients.

Over 90 FDA IND, NDA, BLA, and 505(b)2 successful submissions.

Over 250 FDA CDRH medical device successful submissions.

End-to-End Solutions

Our Solutions

Investors

To find your next opportunity, our team can help assess the commercial feasibility of an asset and provide connections to our portfolio companies that align with your investment thesis.

Incubator Offering

Incubators

Inventors oftentimes do not understand how to efficiently convert a research project into a commercial product. Through our Entrepreneurship Bootcamp, our faculty will cover investor preparedness, regulatory strategy, IP protection, among other core pillars of commercial success.

Resources